Companies: 10,795·Total market cap: $144.5T
United Therapeutics Corporation

United Therapeutics Corporation

UTHRNASDAQHealthcare● Active
$544.69
$-5.18(-0.94%)
Market Cap$23.1B
P/E Ratio—
52W High$609.35
52W Low$272.12
Overview

United Therapeutics Corporation (UTHR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001082554 · UTHR · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,001+
Total Filings
4
Latest Form
2026-06-08
Most Recent
1999
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001082554 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-25
Fiscal Year End
Feb 25, 2026
Accession No.
0001082554-26-000006
Primary Document
uthr-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001082554 · Accession 0001082554-26-000006

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-06Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SDSD
FORM SD
2026-06-02
View
8-KCurrent Report
8-K
2026-05-06
View
10-QQuarterly Report
10-Q
2026-05-06
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-30
View
ARSARS
ANNUAL REPORT TO SECURITY HOLDERS
2026-04-29
View
DEFA14AProxy Statement (Additional)
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
2026-04-29
View
DEF 14AProxy Statement
DEFINITIVE PROXY STATEMENT
2026-04-29
View
8-KCurrent Report
FORM 8-K
2026-03-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
8-KCurrent Report
FORM 8-K
2026-03-09
View
8-KCurrent Report
FORM 8-K
2026-03-02
View
8-KCurrent Report
8-K
2026-02-25
View
10-KAnnual Report
10-K
2026-02-25
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-10
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-01-23
View
Showing 1–15 of 128 filingsForm 4 / 144 hidden· 1001 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001082554  |  Exchange: NASDAQ · Healthcare

United Therapeutics Corporation (NASDAQ: UTHR) has submitted 1,001+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1999. As a Healthcare sector company with CIK 0001082554, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is United Therapeutics Corporation's most comprehensive regulatory disclosure. The most recent United Therapeutics Corporation 10-K was filed on 2026-02-25 for fiscal year ending 2026. Historical UTHR 10-K annual reports are available from 2022 through 2026.

Investors researching United Therapeutics Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
BIIB SEC Filings →ILMN SEC Filings →WAT SEC Filings →RPRX SEC Filings →WST SEC Filings →DGX SEC Filings →INCY SEC Filings →ZBH SEC Filings →
→ UTHR Financials→ UTHR Earnings→ UTHR Insider Trades

Frequently Asked Questions

UTHR SEC Filings · 8 questions

United Therapeutics Corporation (UTHR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,001+ filings and access original documents at no cost. United Therapeutics Corporation's CIK is 0001082554.

UTHR SEC filingsUnited Therapeutics Corporation SEC documentsfind UTHR 10-K